and the Complement System: A Review of the Evasion Strategies

Overview

Journal Microorganisms

Specialty Microbiology

Date 2023 Mar 29

PMID 36985237

Authors

Alex Gonzalez-Alsina

Margalida Mateu-Borras

Antonio Domenech-Sanchez

Sebastian Alberti

Affiliations

Soon will be listed here.

Abstract

The increasing emergence of multidrug resistant isolates of causes major problems in hospitals worldwide. This concern is particularly significant in bloodstream infections that progress rapidly, with a high number of deaths within the first hours and without time to select the most appropriate treatment. In fact, despite improvements in antimicrobial therapy and hospital care, bacteremia remains fatal in about 30% of cases. The complement system is a main defensive mechanism in blood against this pathogen. This system can mark bacteria for phagocytosis or directly lyse it via the insertion of a membrane attack complex in the bacterial membrane. exploits different strategies to resist complement attack. In this review for the special issue on "bacterial pathogens associated with bacteriemia", we present an overview of the interactions between and the complement components and strategies used by this pathogen to prevent recognition and killing by the complement system. A thorough understanding of these interactions will be critical in order to develop drugs to counteract bacterial evasion mechanisms.

Citing Articles

Novel broadly reactive monoclonal antibody protects against infection.

Mateu-Borras M, Dublin S, Kang J, Monroe H, Sen-Kilic E, Miller S Infect Immun. 2024; 93(1):e0033024.

PMID: 39670709 PMC: 11784295. DOI: 10.1128/iai.00330-24.

The potential of bacterial anti-phagocytic proteins in suppressing the clearance of extracellular vesicles mediated by host phagocytosis.

Sun J, Chen C, Pan P, Zhang K, Xu J, Chen C Front Immunol. 2024; 15:1418061.

PMID: 38903499 PMC: 11186983. DOI: 10.3389/fimmu.2024.1418061.

Determinants of bacterial survival and proliferation in blood.

Le-Bury P, Echenique-Rivera H, Pizarro-Cerda J, Dussurget O FEMS Microbiol Rev. 2024; 48(3).

PMID: 38734892 PMC: 11163986. DOI: 10.1093/femsre/fuae013.

Gonzalez-Alsina A, Martin-Merinero H, Mateu-Borras M, Verd M, Domenech-Sanchez A, Goldberg J Front Cell Infect Microbiol. 2024; 14:1328185.

PMID: 38510967 PMC: 10951071. DOI: 10.3389/fcimb.2024.1328185.

Antibody-Mediated Serum Resistance Protects Pseudomonas aeruginosa During Bloodstream Infections.

Hickson S, Hoehensteiger J, Mayer-Coverdale J, Torres V, Feng W, Monteith J J Infect Dis. 2024; 230(2):e221-e229.

PMID: 38235716 PMC: 11326846. DOI: 10.1093/infdis/jiad457.

References

Li H, Luo Y, Williams B, Blackwell T, Xie C . Structure and function of OprD protein in Pseudomonas aeruginosa: from antibiotic resistance to novel therapies. Int J Med Microbiol. 2012; 302(2):63-8. PMC: 3831278. DOI: 10.1016/j.ijmm.2011.10.001. View

Poole K . Pseudomonas aeruginosa: resistance to the max. Front Microbiol. 2011; 2:65. PMC: 3128976. DOI: 10.3389/fmicb.2011.00065. View

Thaden J, Park L, Maskarinec S, Ruffin F, Fowler Jr V, van Duin D . Results from a 13-Year Prospective Cohort Study Show Increased Mortality Associated with Bloodstream Infections Caused by Pseudomonas aeruginosa Compared to Other Bacteria. Antimicrob Agents Chemother. 2017; 61(6). PMC: 5444115. DOI: 10.1128/AAC.02671-16. View

Boucher J, Yu H, Mudd M, Deretic V . Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection. Infect Immun. 1997; 65(9):3838-46. PMC: 175548. DOI: 10.1128/iai.65.9.3838-3846.1997. View

Pier G, Coleman F, Grout M, Franklin M, Ohman D . Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis. Infect Immun. 2001; 69(3):1895-901. PMC: 98099. DOI: 10.1128/IAI.69.3.1895-1901.2001. View

Maeshima N, Fernandez R . Recognition of lipid A variants by the TLR4-MD-2 receptor complex. Front Cell Infect Microbiol. 2013; 3:3. PMC: 3569842. DOI: 10.3389/fcimb.2013.00003. View

Costerton J, Lewandowski Z, Caldwell D, Korber D, Lappin-Scott H . Microbial biofilms. Annu Rev Microbiol. 1995; 49:711-45. DOI: 10.1146/annurev.mi.49.100195.003431. View

Beckmann F, Moll H, Jager K, Zahringer U . Preliminary communication 7-O-carbamoyl-L-glycero-D-manno-heptose: a new core constituent in the lipopolysaccharide of Pseudomonas aeruginosa. Carbohydr Res. 1995; 267(2):C3-7. DOI: 10.1016/0008-6215(94)00371-l. View

Engel L, Hill J, Caballero A, Green L, OCallaghan R . Protease IV, a unique extracellular protease and virulence factor from Pseudomonas aeruginosa. J Biol Chem. 1998; 273(27):16792-7. DOI: 10.1074/jbc.273.27.16792. View

10.

Zaidi T, Zaidi T, Pier G . Role of neutrophils, MyD88-mediated neutrophil recruitment, and complement in antibody-mediated defense against Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci. 2009; 51(4):2085-93. PMC: 2868398. DOI: 10.1167/iovs.09-4139. View

11.

Jones C, Wozniak D . Psl Produced by Mucoid Contributes to the Establishment of Biofilms and Immune Evasion. mBio. 2017; 8(3). PMC: 5478896. DOI: 10.1128/mBio.00864-17. View

12.

Hajjar A, Ernst R, Tsai J, Wilson C, Miller S . Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol. 2002; 3(4):354-9. DOI: 10.1038/ni777. View

13.

Merle N, Noe R, Halbwachs-Mecarelli L, Fremeaux-Bacchi V, Roumenina L . Complement System Part II: Role in Immunity. Front Immunol. 2015; 6:257. PMC: 4443744. DOI: 10.3389/fimmu.2015.00257. View

14.

Baumann U, Wu S, Flaherty K, McKay D . Three-dimensional structure of the alkaline protease of Pseudomonas aeruginosa: a two-domain protein with a calcium binding parallel beta roll motif. EMBO J. 1993; 12(9):3357-64. PMC: 413609. DOI: 10.1002/j.1460-2075.1993.tb06009.x. View

15.

Guo L, Lim K, Poduje C, Daniel M, Gunn J, Hackett M . Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell. 1998; 95(2):189-98. DOI: 10.1016/s0092-8674(00)81750-x. View

16.

Mishra M, Byrd M, Sergeant S, Azad A, Parsek M, McPhail L . Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization. Cell Microbiol. 2011; 14(1):95-106. PMC: 4466118. DOI: 10.1111/j.1462-5822.2011.01704.x. View

17.

Mishra M, Ressler A, Schlesinger L, Wozniak D . Identification of OprF as a complement component C3 binding acceptor molecule on the surface of Pseudomonas aeruginosa. Infect Immun. 2015; 83(8):3006-14. PMC: 4496607. DOI: 10.1128/IAI.00081-15. View

18.

Nouwens A, Beatson S, Whitchurch C, Walsh B, Schweizer H, Mattick J . Proteome analysis of extracellular proteins regulated by the las and rhl quorum sensing systems in Pseudomonas aeruginosa PAO1. Microbiology (Reading). 2003; 149(Pt 5):1311-1322. DOI: 10.1099/mic.0.25967-0. View

19.

Hair P, Sass L, Vazifedan T, Shah T, Krishna N, Cunnion K . Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity. PLoS One. 2017; 12(3):e0173257. PMC: 5344399. DOI: 10.1371/journal.pone.0173257. View

20.

Kang C, Kim S, Park W, Lee K, Kim H, Kim E . Clinical features and outcome of patients with community-acquired Pseudomonas aeruginosa bacteraemia. Clin Microbiol Infect. 2005; 11(5):415-8. DOI: 10.1111/j.1469-0691.2005.01102.x. View